Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But ...

Despite breakthroughs in HIV treatment and prevention worldwide, critical challenges such as stigma, unequal access and ...

Persistence of stigma toward people living with HIV has puzzled scientists looking at the numerous destigmatization campaigns ...

In two phase 3 trials, it was shown to reduce the risk for HIV infection by 96% to 100%. The FDA has accepted Gilead Sciences’ new drug application for lenacapavir as a long-lasting injectable ...

A team of researchers from the University of Florida has developed an innovative handheld device for human immunodeficiency virus (HIV) detection that combines paper-based sample preparation with real ...

Kidney Transplantation Among Those With HIV Infections Shown Safe and Effective, Study Suggests Oct. 17, 2024 — It is just as safe and effective for people with HIV in need of kidney ...

One-shot’ approach that uses machine learning to screen immune cells could help to detect conditions with overlapping ...

The FDA has accepted Gilead Sciences’ new drug application for lenacapavir as a long-lasting injectable to prevent HIV infection and set a date of June 19 to decide on its approval, Gilead ...

The Government has announced it will spend extra £1.5m to help meet its target of ending HIV transmissions in England by 2030. The money will be spent on more than 20,000 self-testing and ...

In a joint survey by Aidsfonds, GNP+ and the Robert Carr Fund 22% of organizations reported increased experiences of discrimination, including reports of discrimination within healthcare settings, ...

Earlier in the week, the Vatican had said the 88-year-old had a “polymicrobial infection of the respiratory tract.” These are the latest in a series of lung-related health concerns that have ...